BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38542325)

  • 21. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
    Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
    PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing snail expression.
    Heiden KB; Williamson AJ; Doscas ME; Ye J; Wang Y; Liu D; Xing M; Prinz RA; Xu X
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2178-87. PubMed ID: 25078145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.
    Awad O; Yustein JT; Shah P; Gul N; Katuri V; O'Neill A; Kong Y; Brown ML; Toretsky JA; Loeb DM
    PLoS One; 2010 Nov; 5(11):e13943. PubMed ID: 21085683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
    Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
    Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer stem cell antigen nanodisc cocktail elicits anti-tumor immune responses in melanoma.
    Aikins ME; Qin Y; Dobson HE; Najafabadi AH; Lyu K; Xu Y; Xin Y; Schwendeman A; Wicha MS; Chang AE; Li Q; Moon JJ
    J Control Release; 2022 Nov; 351():872-882. PubMed ID: 36206945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma.
    Emori M; Tsukahara T; Murase M; Kano M; Murata K; Takahashi A; Kubo T; Asanuma H; Yasuda K; Kochin V; Kaya M; Nagoya S; Nishio J; Iwasaki H; Sonoda T; Hasegawa T; Torigoe T; Wada T; Yamashita T; Sato N
    PLoS One; 2013; 8(12):e84187. PubMed ID: 24376795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.
    Yamada T; Abei M; Danjoh I; Shirota R; Yamashita T; Hyodo I; Nakamura Y
    BMC Cancer; 2015 Apr; 15():260. PubMed ID: 25885470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcoma.
    Skubitz KM; Wilson JD; Cheng EY; Lindgren BR; Boylan KLM; Skubitz APN
    J Transl Med; 2019 Apr; 17(1):130. PubMed ID: 30999901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells.
    Cheng JY; Hung JT; Lin J; Lo FY; Huang JR; Chiou SP; Wang YH; Lin RJ; Wu JC; Yu J; Yu AL
    Front Immunol; 2021; 12():791551. PubMed ID: 35046949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
    Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
    Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cells.
    Kim SK; Kim H; Lee DH; Kim TS; Kim T; Chung C; Koh GY; Kim H; Lim DS
    PLoS One; 2013; 8(10):e78130. PubMed ID: 24194908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity.
    Canter RJ; Borys D; Olusanya A; Li CS; Lee LY; Boutin RD; Christensen SD; Tamurian RM; Monjazeb AM
    Ann Surg Oncol; 2014 May; 21(5):1616-23. PubMed ID: 24554062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
    Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
    Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
    Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy.
    Sharrow AC; Perkins B; Collector MI; Yu W; Simons BW; Jones RJ
    Gynecol Oncol; 2016 Aug; 142(2):341-8. PubMed ID: 27017984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.
    Song W; Ma Y; Wang J; Brantley-Sieders D; Chen J
    Cancer Res; 2014 May; 74(9):2444-54. PubMed ID: 24607842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
    Januchowski R; Wojtowicz K; Zabel M
    Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy.
    Zhang S; Yang Z; Qi F
    Mol Biol Rep; 2020 Feb; 47(2):1435-1443. PubMed ID: 31838656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.